Core Scientific Inc (NASDAQ:CORZ) has a beta value of 6.93 and has seen 5.89 million shares traded in the recent trading session. The company, currently valued at $3.06B, closed the recent trade at $10.96 per share which meant it lost -$0.32 on the day or -2.86% during that session. The CORZ stock price is -69.98% off its 52-week high price of $18.63 and 76.19% above the 52-week low of $2.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 7.9 million shares traded. The 3-month trading volume is 10.99 million shares.
The consensus among analysts is that Core Scientific Inc (CORZ) is Buy stock at the moment, with a recommendation rating of 1.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.03.
Core Scientific Inc (NASDAQ:CORZ) trade information
Sporting -2.86% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CORZ stock price touched $10.96 or saw a rise of 34.13%. Year-to-date, Core Scientific Inc shares have moved -22.01%, while the 5-day performance has seen it change -28.24%. Over the past 30 days, the shares of Core Scientific Inc (NASDAQ:CORZ) have changed -26.76%. Short interest in the company has seen 44.67 million shares shorted with days to cover at 3.78.
Wall Street analysts have a consensus price target for the stock at $16.5, which means that the shares’ value could jump 33.58% from the levels at last check today. The projected low price target is $14.0 while the price target rests at a high of $24.0. In that case, then, we find that the latest price level in today’s session is -118.98% off the targeted high while a plunge would see the stock gain -27.74% from the levels at last check today.
Core Scientific Inc (CORZ) estimates and forecasts
Figures show that Core Scientific Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 7.32% over the past 6 months, with this year growth rate of -2,729.41%, compared to 9.80% for the industry. Revenue growth from the last financial year stood is estimated to be 1.64%.
12 analysts offering their estimates for the company have set an average revenue estimate of 97.33M for the current quarter. 7 have an estimated revenue figure of 108.96M for the next ending quarter. Year-ago sales stood 141.93M and 179.29M respectively for this quarter and the next, and analysts expect sales will shrink by -31.43% for the current quarter and 1.64% for the next.
CORZ Dividends
Core Scientific Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
Insiders own 10.89% of the company shares, while shares held by institutions stand at 67.23% with a share float percentage of 75.45%. Investors are also buoyed by the number of investors in a company, with Core Scientific Inc having a total of 335.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of Sep 30, 2024, the former fund manager holds about 2.50% shares in the company for having 6.99 shares of worth $77.29 million while later fund manager owns 4.59 shares of worth $50.76 million as of Oct 31, 2024, which makes it owner of about 1.64% of company’s outstanding stock.
